The Vanguard Extended Market ETF aims to follow the S&P Completion Index, giving investors exposure to the U.S. equity market outside the S&P 500. In practice, this means a diversified collection of around 3,300 small- and mid-cap names listed on the NYSE and Nasdaq, chosen via an index-sampling method. From what I see, this setup makes VXF a straightforward way to fill in the gaps when pairing it with large-cap holdings for broader market coverage.
Sector allocations show Technology at about 21.7% of the portfolio, followed by Industrials at 18.9%, Healthcare at 15.2%, and Financial Services at 14.3%, with the rest spread across consumer, real estate, energy, materials, communication services, and utilities. Top holdings stay relatively small, each under roughly 2.5% of assets, and feature names like SpaceX, SNOW, NET, NTRA, MSTR, ALAB, LNG, Twilio, Revolution Medicines, and RKLB. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As a passive vehicle, VXF keeps costs low with its 0.05% expense ratio while overseeing around $91 billion in assets. This structure positions it as a common complement to S&P 500 funds for those seeking fuller U.S. market representation.
Performance in this segment often hinges on the rate-sensitive and cyclical nature of smaller companies. Unlike large-cap indexes heavy in a few dominant tech names, the extended universe includes thousands of firms whose prospects tie closely to credit availability, capital spending, and overall economic expansion. One thing that stands out is how themes like cloud adoption and AI infrastructure show up through holdings such as Snowflake, Cloudflare, and Astera Labs, while space innovation appears via SpaceX and Rocket Lab, biotech via Natera and Revolution Medicines, and energy infrastructure via Cheniere Energy and Bloom Energy. Industrials and financials, as major sectors here, remain particularly attuned to interest-rate shifts and U.S. growth trends.
Over the past 30 days, VXF has fallen about 3.7%, with a roughly 7.5% decline over the trailing quarter. This reflects a general easing in risk appetite for smaller equities rather than any isolated event. The fund’s beta of around 1.1 tends to magnify broader market swings, which aligns with its growth tilt and higher sensitivity compared with large-cap benchmarks. I’m watching this closely because smaller firms often carry more debt and elevated valuations, making them responsive to changes in financing costs and growth expectations. Dispersion within the portfolio has been evident too, with some AI-linked holdings holding up better at times while cyclical areas lagged.
Monetary policy and interest-rate paths will probably remain key influences, given the fund’s exposure to rate-sensitive areas. Inflation patterns and economic growth momentum could also steer flows toward or away from higher-beta names. Earnings trajectories for core holdings matter as well—continued spending on cloud and AI infrastructure may support related software and chip-adjacent positions, while biotech progress, aerospace demand, and energy infrastructure buildouts could affect other segments. Additional items to track include inflows into small- and mid-cap strategies, the valuation spread versus large caps, and fee competition among similar funds. Risks worth noting include a sharper economic slowdown, sustained high rates, or over-concentration in high-multiple growth stocks, any of which might pressure relative results.
In my own research process, Tickeron’s AI Screener has proven useful for scanning the broader universe of small- and mid-cap names. It applies technical indicators, fundamentals, volatility data, AI signals, trends, and patterns to surface opportunities more efficiently than manual methods. For someone following a fund like VXF, this kind of platform helps monitor sector shifts and emerging themes across the extended market without getting overwhelmed by the thousands of holdings involved.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
VXF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 37 cases where VXF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VXF's RSI Indicator exited the oversold zone, 22 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
Following a +1.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where VXF advanced for three days, in 272 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 61 cases where VXF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VXF as a result. In 76 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for VXF turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VXF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for VXF entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapBlend